From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...

Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...